secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORDSON CORP (NDSN)
CIK:        0000072331
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0001193125-24-147674
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nordson to acquire Atrion for $460/share in cash, ~$800M enterprise value
-------------------------------------------------------------------------

- Deal price $460/share cash; enterprise value ~$800M; 15x 2024 estimated EBITDA including expected synergies.
- Atrion 2023 revenue ~$169M; key businesses: Halkey Roberts, Atrion Medical, Quest Medical in infusion and cardiovascular.
- Expected close before Nordson fiscal year-end Oct 2024; funded by cash on hand and new debt.
- Three FDA-registered U.S. manufacturing facilities expand Nordson MEDICAL's addressable market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72331/000119312524147674/0001193125-24-147674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72331/000119312524147674/d836379d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-147674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer